- Rising Health Costs Push Some Middle-Aged Adults To Skip the Doc Until Medicare
- Even With Dental Insurance, You Still Could Face a Large Bill
- Don't Forget This: Study Shows Cannabis Exacts a Toll on Your Memory
- Want To Stress Less? Start With These Everyday Habits
- Journalists Shine Light on Out-of-Reach Insurance Prices, AI’s Role in Claims Disputes, and Susie Wiles
- Arizona behavioral health center adds 10 adolescent beds
- The explosion of the Medicare Advantage special needs plan
- The explosion of the Medicare Advantage special needs plan
- We’re Great Thinkers…But Not Rethinkers
- North Star to cut additional jobs
- North Star to cut additional jobs
- Oregon Governor asks PeaceHealth to delay contract switch: 11 things to know
- 6 Optum updates to know from Q1
- Viewpoint: US nursing workforce faces several risks
- The shifting dental hygiene landscape
- 12 dental insurance updates in 30 days
- ‘The 1980s called’: CMS to phase out fax, mail
- ‘The 1980s called’: CMS to phase out fax, mail
- Aligning IT & clinical teams: How to reduce friction and improve communication
- AI tool targets billing gaps at Kentucky system
- AI in pharmacy: Why pilots stall at hospitals
- 37 recent hospital, health system executive moves
- This ASC startup is wiring AI into the fabric of outpatient surgery
- Springer Nature retracts 38 papers over autism dataset
- Intermountain plans new outpatient clinic
- Legacy Health, Regence BCBS face looming contract expiration
- Meet the COOs of the largest DSOs
- Michigan bills target outpatient fees, CON requirements
- Anesthesia group, lawmakers oppose Medicare cuts to non-opioid pain treatment
- Iowa lifts emergency suspension of transplant surgeon’s license
- Vascular center, physician CEO to pay $4M to settle fraud allegations
- In the Affordability Alphabet Soup of the ACA and EHBs, a Link to Higher Premiums Isn’t Clear-Cut
- 5 cardiologists stepping into leadership roles
- New York organizations partner on intellectual, developmental disabilities campus
- Cincinnati hospital acquires outpatient center for $6M
- CMS final rule aims to axe the fax machine, phase out paper mailing
- 24 profitable health systems in 2025
- How 2 CFOs plan for uncertainty
- Heartland Dental expands with Texas affiliation
- MD Anderson opens colorectal cancer center
- SALT Dental Partners adds Washington practice
- 11 dental school updates to know
- 6 health systems seeking revenue cycle executive directors
- Remarks at The SEC Speaks in 2026: From Kitchen Table to Cap Table—Making Capital Formation Work for Small Businesses
- Integrated care model drives 76% depression improvement in 44 days: Study
- Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
- Survey Shows More People Struggling To Afford ACA Insurance
- Up to 155,000 COVID Deaths May Not Have Been Counted, Study Finds
- FDA Drops Plan To Ban Tanning Beds for Minors Nationwide
- Idaho bill proposes consolidating dental regulatory oversight
- Washington hospital charts path to preserve primary care
- 4 DSOs making headlines
- 6 state behavioral health policy updates
- 80% of returning ACA enrollees report higher healthcare costs in 2026
- Fitch downgrades HonorHealth’s credit rating
- NYC Health + Hospitals names dentistry, oral surgery leaders
- Mindray North America Enters Ventilator Market
- Mindray North America Enters Ventilator Market
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics
- Sanofi backs 2 more documentary films about rare blood disorders
- ACIP member's miscommunication on vaccine panel's future adds to confusion after court ruling
- Rhythm's Imcivree scores 'transformative' FDA approval in brain damage-related obesity
- Some Patients With ADHD and Addiction History Missing Out
- Social Media Poses Risks to Children's Mental Health, Review Concludes
- 'Early Bird' Exercisers Get The Most Health Benefits, Study Finds
- Does Closing Your Eyes Help You Hear Better?
- High Blood Pressure Deaths Quadruple Among Young Women, Study Finds
- Meningitis Vaccine Doesn't Protect Gay, Bisexual Men From Gonorrhea, Clinical Trial Concludes
- Oz Escalates Medicaid Fraud Claims Against States After Focus on Minnesota
- Listen: Trump’s NIH ‘Reset’ Is Driving Away Scientists
- ‘How Low Can You Go?’ The Shifting Guidelines for Blood Pressure Control
- Mississippi to fund clinical trials for psychedelic drug
- Lawmakers push bill to boost mental health workforce, diversity
- Florida State partners with behavioral health provider on research
- Utah governor signs hygienist autonomy bill
- UHS CEO: Talkspace deal builds 1st national ‘end-to-end’ behavioral model
- Psychedelic therapy shows no benefit over antidepressants: Study
- What the Health? From KFF Health News: RFK Jr.’s Vaccine Schedule Changes Blocked — For Now
- Verily banks $300M to accelerate AI road map, transitions to independent company
- KFF: ACA plan enrollees report rising costs for 2026 coverage
- Industry Voices—Stop buying AI tools, start designing AI architecture
- CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix
- 10K Corewell Health nurses vote to authorize labor strike
- Providence mulling sale of its health plan amid financial pressures
- Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup
- Gut Microbiome May Take Years to Recover From Antibiotic Use
- Prepared Remarks Before SEC Speaks
- The Art and Science of Materiality
- Capital, Choice, and the Pursuit of Happiness: Remarks at The SEC Speaks in 2026
- Novo's Wegovy HD passes muster under FDA national priority voucher program
- Hospital operations begin 2026 with depressed margins amid low volumes, high labor spend
- The Math Behind Eczema Flare-Ups May Finally Add Up
- Male preconception startup Upstream announces donor-matching platform
- Women's health sector could grow to $600B industry by 2030: PwC report
- Democratic senators detail plans to take on 'Big Insurance'
- Both Types Of Diabetes Increase Dementia Risk
- Aldi Recalls Spinach Bites Over Possible Contamination
- Collegium ponies up $650M to gain ADHD drug Azstarys from Corium
- Maryland bill calls for more transparency in pharma's disease awareness campaigns
- After Alfasigma's GSK licensing deal, Lynavoy picks up FDA nod in rare liver disease
- What To Know About Fatty Liver Disease and Why It’s So Common
- Drug Smoking Linked To Surge In Severe Burn Cases
- Thymus Gland Health May Be Key to Long Life and Fighting Cancer
- Premature Menopause Increases Heart Disease Risk
- U.S. Teen Obesity Hits Record Highs While Efforts to Slim Down Drop
- Pesticide Exposure Before Pregnancy Might Risk Newborn Health
- UPDATED: AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai
- Many ACA Customers Are Paying Higher Premiums. Most Blame Trump and Republicans, Poll Finds.
- Lawmakers Seek To Protect Crisis Pregnancy Centers as Abortion Clinic Numbers Shrink
- CDMO Axplora to pump $60M into Italian complex API plant
- Pfizer eyes earlier Talzenna use after phase 3 prostate cancer win
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- Turquoise Health raises $40M to power healthcare contracts, payments
- To tackle healthcare costs, representatives weigh curbs on provider consolidation
- A look at Highmark's specialty pharmacy partnership with Free Market Health
- AD/PD 2026: New data highlight potential cost-effectiveness of confirmatory AD blood testing in U.S. diagnostic pathways
- With downgrade, HSBC casts doubt about Lilly's 'stairway to heaven' trajectory
- TrumpRx's 'world's lowest' drug price claims fall short in global comparison: NYT
- Study Finds Little Proof Cannabis Helps Most Mental Health Conditions
- Meningitis Outbreak Tied to Students Leaves 2 Dead and 11 Sick in England
- J&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval
- Belly Fat Linked To Heart Failure Risk
- Women More Likely To Survive Cancer Than Men — At A Cost
- BMS brings 'Emily in Paris' star and cancer survivor Ashley Park aboard campaign honoring oncologists
- Sandoz expands biosim collab with Samsung Bioepis, sets sights on Takeda's Entyvio
- Ultra-Processed Foods Linked To Heart Attack, Stroke, Cardiac Arrest
- E. Coli Outbreak Tied To Raw Cheddar Cheese Sickens 7 People
- The Sunshine Vitamin and COVID: New Study Finds Mixed Results for Recovery
- Too Much Smartphone Use Linked to Disordered Eating in Teens
- Shingles Vaccine Protects Heart Failure Patients From Heart Attack, Stroke
- White House Chief of Staff Susie Wiles Diagnosed With Early Breast Cancer
- Gates-backed TerraPower Isotopes blueprints $450M plant to supply next wave of radiopharmaceuticals
- Regulation Crypto Assets: A Token Safe Harbor
- The Last Chapter in the Book of Howey
- Payers, hospitals pan CMS' plan to bring non-network plans to ACA exchanges
- Optum Real and Suki build out collaboration to tackle payment challenges as R1 teams with AI scribe Heidi
- Indiana homes in on life sciences with $1B growth strategy, plan to create 100K jobs
- Moody's: Insurers' 2026 outlook is negative as cost pressures continue to batter industry
- GSK's management of Flovent allowed it to 'game the system': Hassan
- Allina Health to join Sutter Health in $26B proposed transaction
- Norovirus Sickens Close to 200 People on Caribbean Cruise
The Democrats have gotten a lot of political mileage out of KFF's lie that PPACA health plan (ObamaCare) premiums will double at the end of this year. This lie - rebroadcast by idiot reporters - was the driving force behind weak kneed RINOs signing on to the bogus Congressional Discharge Petition 10. Chris Jacobs at Juniper Research brings the receipts:
The Health Care-Industrial Complex Is Lying About Obamacare Premiums Doubling — And They Know It
By Christopher Jacobs - December 22, 2025
Many reporters have taken KFF’s claim that ‘premium payments will double’ to mean that total ‘premiums will double,’ but that’s just not true.When others frequently misinterpret an organization’s claim, is the problem the messenger, the message, or both? Journalists — including some on its own staff — continue to draw incorrect conclusions from the work of KFF, formerly the Kaiser Family Foundation, about the Dec. 31 expiration of enhanced, Covid-era insurance subsidies. Yet KFF refuses to alter its message, suggesting a deeper ideological bias in its work.
No, Premiums Aren’t Doubling
To separate spin from facts and briefly summarize what I have stated in greater detail elsewhere: KFF’s claim that “premium payments will more than double” if the enhanced subsidies expire conflates total premiums with the net portion of premium enrollees pay out of pocket, even though the original, circa-2010 Obamacare subsidy regime will still pay 75-80 percent of the average enrollee’s premium. Moreover, because nearly half of enrollees currently qualify for benchmark coverage with no out-of-pocket premiums, focusing on percentages obscures the fact that most (but not all) households will face a modest out-of-pocket increase of roughly $50-100 per month.
Many reporters have taken KFF’s claim that “premium payments will double” to mean that total “premiums will double.” In one case, a writer at Axios acknowledged the error and corrected it. But no sooner had I convinced an editor at The Hill to correct a story claiming “premiums will double” — not least because KFF itself had called this wording inaccurate — than another story from the same publication also included an incorrect claim about premiums doubling. A CNN reporter cited KFF as a reason not to adjust her claim that “premiums will double,” even after I showed her evidence that KFF personnel concede this wording is inaccurate.
Continuing Use of a Misleading Slogan
Most notably, KFF’s Health News team made the same inaccurate claim that “premiums will double” in an article about health costs. When questioned about it, the publication appended a clarification to the story. But the incident raises more fundamental questions: Why does KFF keep using a phrase that its own reporters do not understand? And would KFF Health News, which purportedly “has editorial independence for story ideas and content,” take a critical look at the confusing terminology used by KFF researchers?
KFF declined to answer either question. KFF Health News Executive Editor Alex Wayne did not respond to my question about whether his team would scrutinize its parent organization, and KFF researchers ignored my request to issue a press release clarifying their statements and phraseology.
Reporters often describe KFF as “nonpartisan” because it, like other 501(c)(3) entities, cannot engage in party political activities. But that doesn’t mean the organization doesn’t hold ideological biases. President Drew Altman has admitted as much: “Topic selection can convey bias every bit as much as study or poll or story selection can.”
Word selection can convey bias too. KFF advertises a focus on “communications strategies that will earn trust,” but has used phrasing that multiple media outlets, including several so-called reporters specializing in health policy, have misinterpreted. When KFF persists in using this terminology, and its executives use phrases like “eye-popping premium increases” to describe cost effects averaging $50-100 per month, it’s reasonable to question whether KFF’s mission — which “is at its core … about inequality and economic security, racism, and the future of our diverse society” — has biased its work.
Press or Propaganda?
At stake is far more than what some might dismiss as semantic arguments about wonky policy terminology. KFF Health News advertises itself as the “largest health newsroom in the country.” When that newsroom, despite its claims of “editorial independence,” will not take a critical look at KFF research, then it becomes little more than a mouthpiece for the parent organization. And a wide swath of health care stories nationwide will reflect that organization’s ideological slant, which is perhaps the point.
Reasonable people can disagree about the effects of a $50-100 monthly cost increase on households of modest means if the enhanced subsidies expire. But KFF’s continued use of misleading terminology suggests an ideology that would conjure objections if the average financial effect on enrollees were $10 or $10,000. Neither readers nor reporters should disabuse themselves of the organization’s biases.
Chris Jacobs is founder and CEO of Juniper Research Group and author of the book "The Case Against Single Payer." He is on Twitter: @chrisjacobsHC.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















